Is there a universal drug for epilepsy?
https://doi.org/10.17749/2077-8333.2018.10.2.095-103
Abstract
The article reviews the use of antiepileptic drugs in various forms of epilepsy. We present a complex case of juvenile myoclonic epilepsy, the diagnostic process and antiepileptic therapy. Our own data and the results of others demonstrated a high efficacy and tolerability of valproate drugs, and a low aggravation potential in all types of epileptic seizures.
About the Authors
S. G. BurdRussian Federation
1 Ostrovityanova Str., Moscow 117997, Russia
MD, Professor, Department of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics, Pirogov Russian National Research Medical University
A. V. Lebedeva
Russian Federation
1 Ostrovityanova Str., Moscow 117997, Russia
MD, Professor, Department of Neurology, Neurosurgery and Medical Genetics, Faculty of Medicine, N. I. Pirogov Russian National Research Medical University; Scientific Research Institute of Healthcare and Medical Management of the Moscow City Health Department
Yu. V. Rubleva
Russian Federation
1 Ostrovityanova Str., Moscow 117997, Russia
Postgraduate Student, Pirogov Russian National Research Medical University
M. B. Mironov
Russian Federation
13/32 Andropov Avenue, Moscow 101100, Russia
PhD, Head of the Laboratory of Video EEG-Monitoring at the Medical Center for Pediatric Neurology and Pediatrics
T. M. Krasilshikova
Russian Federation
1 Ostrovityanova Str., Moscow 117997, Russia
Assistant, Department of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics, Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
References
1. Sankaraneni R., Lachhwani D. Antiepileptic drugs – a review. Pediatr Ann. 2015; 44(2): e36-42. DOI: 10.3928/00904481-20150203-10.
2. Glauser T., Ben-Menachem E., Bourgeois B. et al. Updated ILAE evidence review of AED efficacy and effectiveness as initial monotherapy for epileptic seizure and syndromes. Epilepsia. 2013; 54 (3): 551-563. DOI: 10.1111/epi.12074.
3. Coppola G., Piccorossi A., Operto F.F., Verrotti A. Anticonvulsant drugs for generalized tonic-clonic epilepsy. Expert Opin Pharmacother. 2017; 18 (9): 925-936. DOI: 10.1080/14656566.2017.1328499.
4. Resolution of the National Scientific Council of Experts in "Determining the possibility of increasing remission in patients with partial epilepsy" Epilepsy and paroxysmal conditions. Epilepsiya i paroksizmal'nye sostoyaniya / Epilepsy and paroxysmal conditions (in Russian). 2017; 9 (3): 73-76.
5. Genton P., Gelisse P., Thomas P., Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology. 2000; 55:1106-9. DOI:10.1212/WNL.55.8.1106.
6. Thomas P., Valton L., Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain. 2006; 129:1281-92. DOI:10.1093/brain/awl047.
7. Muhin K.Yu., Petruhin A.S., Mironov M.B. Valproate sodium (Depakin) in achieving remission in patients with idiopathic generalized epilepsy (long-term catamnesis). The neurological journal / Nevrologicheskiy zhurnal (in Russian). 2004; 4: 34-39.
8. Engel J. Jr. Report of the ILAE Classification Core Group. Epilepsia. 2006; 47 (9): 1558-1568.
9. Vlasov P.N. Algorithms for the diagnosis and treatment of epilepsy in adults in outpatient conditions (in Russian)]. Farmateka. 2006; (7): 96-104.
10. Gusev E.I., Konovalov A.N., Skvortsova V.I. Neurology. National leadership, 2nd edition, revised and supplemented [Nevrologiya. Natsional'noe rukovodstvo, 2-e izdanie, pererabotannoe i dopolnennoe (in Russian)]. Moscow. 2018; s. 414.
11. Muhin K.Yu., Petruhin A.S., Mironov M.B. Epileptic syndromes. Diagnosis and therapy. Reference guide for doctors [Epilepticheskie sindromy. Diagnostika i terapiya. Spravochnoe rukovodstvo dlya vrachey (in Russian)]. Moscow. 2008; 223 s.
12. Muhin K.Yu., Petruhin A.S., Gluhova L.Yu. Benign epileptiform disorders of childhood and their specificity. Epilepsy: atlas of electro-clinical diagnosis [Dobrokachestvennye epileptiformnye narusheniya detskogo vozrasta i ih spetsifichnost'. Epilepsiya: atlas elektroklinicheskoy diagnostiki (in Russian)]. 2004; Moscow. 277-288.
13. Muhin K.Yu., Mironov M.B. Frequency of occurrence of various forms of idiopathic focal epilepsy in children. Epilepsiya i paroksizmal'nye sostoyaniya / Epilepsy and paroxysmal conditions (in Russian). 2011; 3: 33-37.
14. Liu M.J., Su X.J., Md X.S., Wu G.F., Zhang Y.Q., Gao L., Wang W., Liao J.X., Wang H., Mai J.N., Gao J.Y., Shu X.M., Huang S.P., Zhang L., Zou L.P. Clinical features of benign epilepsy of childhood with centrotemporal spikes in chinese children. Medicine (Baltimore). 2017 Jan; 96 (4): e5623. DOI: 10.1097/MD.0000000000005623.
15. Xiao F., An D., Deng H., Chen S., Ren J., Zhou D. Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS). Seizure. 2014 Oct; 23 (9): 756-61. DOI: 10.1016/j.seizure.2014.06.006.Epub 2014 Jun 21.
16. Skrijelj F., Sokić D. Dilemmas in diagnostics and therapy of rolandic epilepsy. Vojnosanit Pregl. 2011; 68 (6): 526-8.
17. Hughes J.R. Benign epilepsy of childhood with centrotemporal spikes (BECTS): to treat or not to treat, that is the question. Epilepsy Behav. 2010 Nov; 19 (3): 197- 203. DOI: 10.1016/j.yebeh.2010.07.018. Epub 2010 Aug 24.
18. Oguni H. Treatment of benign focal epilepsies in children: when and how should be treated? Brain Dev. 2011 Mar; 33 (3): 207-12. DOI:10.1016/j.braindev.2010.10.024. Epub 2010 Nov 20.
19. Wheless J.W., Clarke D.F., Arzimanoglou A., Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. 2007 Dec; 9 (4): 353-412. DOI: 10.1684/epd.2007.0144.
20. Homyakova S.P., Muhin K.YU., Petruhin A.S., Alihanov A.A. Diagnosis and treatment of Rolandic epilepsy. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova / Journal of Neurology and Psychiatry. S.S. Korsakov (in Russian). 1999; 99 (3): 16- 21.
21. Panayiotopoulos C.P., Bureau M., Caraballo R.H., Bernandina B.D., Valeta T. Idiopathic focal epilepsies in childhood. In; Bureau M., Genton P, Dravet C., et al (eds). Epileptic syndromes in infancy, childhood and adolescence, 5 th with video. Montrouge, France; John Libbey Eurotext; 2012; 217-254.
22. Avakyan G.N., Blinov D.V., Lebedeva A.V., Burd S.G. et al. ILAE Classification of the epilepsies : the 2017 revision and update. Epilepsiya i paroksizmal'nye sostoyaniya / Epilepsy and paroxysmal conditions (in Russian). 2017; 9 (1): 6-25. DOI: 10.17749/2077-8333.2017.9.1.006-025.
23. Saetre E., Abdelnoor M., Amlie J. P., Tossebro M., Perucca E., Taubøll E., Anfinsen, J. Isojärvi O. G., Gjerstad L. Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine. Epilepsia. 2009; 50 (8): 1841-9.
24. Svalheim S., Aurlien D., Amlie J.P., Gjerstad L., Taubøll E. Signal-averaged and standard electrocardiography in patients with newly diagnosed epilepsy. Epilepsy Behav. 2012; 25 (4): 543-5.
25. Bruun E., Virta L.J., Kälviäinen R., Keränen T. Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy. Epilepsy Behav. 2017 Aug; 73: 71-76. DOI: 10.1016/j.yebeh.2017.05.022.
Review
For citations:
Burd S.G., Lebedeva A.V., Rubleva Yu.V., Mironov M.B., Krasilshikova T.M. Is there a universal drug for epilepsy? Epilepsy and paroxysmal conditions. 2018;10(2):95-103. (In Russ.) https://doi.org/10.17749/2077-8333.2018.10.2.095-103

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.